CLINICAL_TRIALS
trial_result
· 2020-11-23
Clinical Trial Update: Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT) [Phase 2]
Summary
Phase 2 trial exploring pembrolizumab effects on natural killer cell exhaustion in melanoma was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nina Bhardwaj | Conditions: Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2020-11-23